https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/730497 Wed, 22 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730497-cms-to-bridge-coverage-for-obesity-drugs-as-balance-teeters Generic injection pens http://www.bioworld.com/articles/730573 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730573-med-tech-financings-steady-at-88b-in-q1-despite-volume-drop Layered charts http://www.bioworld.com/articles/730472 Mon, 20 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730472-targeted-therapies-dominate-marchs-five-nme-approvals FDA Approved seal http://www.bioworld.com/articles/730466 Mon, 20 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730466-aiming-to-jimi-the-regulatory-lock-in-psychedelics Pills shaded in psychedelic colors http://www.bioworld.com/articles/730474 Mon, 20 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730474-biggest-gainers-and-losers-for-april-13-17-2026 http://www.bioworld.com/articles/730511 Fri, 17 Apr 2026 13:00:00 -0400 https://www.bioworld.com/articles/730511-biopharma-money-raised-jan-1-april-16-2026 http://www.bioworld.com/articles/730510 Fri, 17 Apr 2026 13:00:00 -0400 https://www.bioworld.com/articles/730510-money-raised-by-biopharma http://www.bioworld.com/articles/730396 Thu, 16 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730396-med-tech-financings-steady-at-88b-in-q1-despite-volume-drop Layered charts http://www.bioworld.com/articles/730314 Wed, 15 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730314-flow-of-trump-eos-slowing-way-down Nature that delved into mechanisms that rev up the NLRP3 inflammasome.]]> http://www.bioworld.com/articles/730313 Wed, 15 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730313-in-the-mix-post-ventyx-more-nlrp3s-to-seize NLRP3 inflammasome http://www.bioworld.com/articles/730312 Wed, 15 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730312-abbotts-exact-acquisition-drives-med-tech-m-and-a-to-237b-in-march Handshake, money, calculator, MA-letters http://www.bioworld.com/articles/730308 Wed, 15 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730308-revolution-medicines-15b-follow-on-highest-to-date Dollar sign on financial stock market chart background http://www.bioworld.com/articles/730418 Tue, 14 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730418-biologics-in-development-outnumber-small-molecules-for-the-first-time Drug research illustration http://www.bioworld.com/articles/730417 Tue, 14 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730417-biopharma-deal-value-gains-17-in-early-2026 Gold wireframe handshake http://www.bioworld.com/articles/730283 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730283-biopharma-deal-value-gains-17-in-early-2026 Gold wireframe handshake http://www.bioworld.com/articles/730223 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730223-lipid-reading-street-not-deaf-to-acc-data Cholesterol plaque in artery http://www.bioworld.com/articles/730286 Mon, 13 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730286-biggest-gainers-and-losers-for-april-6-10-2026 http://www.bioworld.com/articles/730324 Fri, 10 Apr 2026 13:00:00 -0400 https://www.bioworld.com/articles/730324-biopharma-money-raised-jan-1-april-9-2026 http://www.bioworld.com/articles/730323 Fri, 10 Apr 2026 13:00:00 -0400 https://www.bioworld.com/articles/730323-money-raised-by-biopharma Pharma Annual Review 2026, published by Pharmaprojects, a firm that tracks global pharma R&D.]]> http://www.bioworld.com/articles/730343 Fri, 10 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730343-biologics-in-development-outnumber-small-molecules-for-the-first-time Drug research illustration http://www.bioworld.com/articles/730211 Thu, 09 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730211-biologics-in-development-outnumber-small-molecules-for-the-first-time Drug research illustration http://www.bioworld.com/articles/730210 Thu, 09 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730210-ipo-market-strengthens-in-q1-2026-as-biopharma-financings-reach-2282b Virtual IPO word with stock graph and arrow http://www.bioworld.com/articles/730209 Thu, 09 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730209-pediatric-prvs-top-the-voucher-popularity-contest Pediatric exam http://www.bioworld.com/articles/730150 Wed, 08 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730150-merck-wnt-first-surrozen-goes-next-in-amd-dme Illustration of Wnt signaling pathway http://www.bioworld.com/articles/730138 Tue, 07 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730138-vc-activity-drives-march-med-tech-financings-to-24b Hand holding smartphone with dollar sign, arrows hovering http://www.bioworld.com/articles/730135 Tue, 07 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730135-kennedy-sidestepping-court-order-sidelining-acip Businessman signing documents http://www.bioworld.com/articles/730236 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730236-sector-tariff-now-more-than-a-threat-for-some-rx-companies Digital globe illustrating pharma trade, tariffs http://www.bioworld.com/articles/730235 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730235-biopharma-financings-nearly-double-vs-2025-to-251b Gray and green glass dollar symbols with arrow pointing up http://www.bioworld.com/articles/730119 Mon, 06 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730119-biopharma-financings-nearly-double-vs-2025-to-251b Gray and green glass dollar symbols with arrow pointing up http://www.bioworld.com/articles/730117 Mon, 06 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730117-circuit-split-forming-over-state-340b-laws Gavel and pill blister packs